Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-intubated intravenous anesthesia with esketamine for pediatric venous port implantation
ChiCTR2200060384Phase 4Recruiting
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine in cancer (2 arms), sponsored by Sun Yat-sen University Cancer Center. Primary endpoint: Recovery time. Started May 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
cancer
Beyond the preview
Go deeper on ChiCTR2200060384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060384.